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346a Monday, February 17, 2014s is stress, ε is strain, and q is the phase shift. We found that both the viscous
modulus and the elastic modulus were higher in the AI KO at high fre-
quencies. These results suggest that WT passive tension levels rely on an
intact A-I junction; the removal of this region results in increased titin
stiffness.
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Background: A well-established function of titin is the determination of pas-
sive tension (Fpassive) in myocardium. Modifications to the elastic titin region
have been suggested to contribute to left ventricular (LV) diastolic dysfunction
in heart failure (HF). Titin-based stiffness can be modulated by isoform switch
or phosphorylation.
Results:We find that titin-isoform switch accounts for a significant amount of
myocardial stiffness modulation, giving rise to increased or reduced Fpassive in
different types of heart failure. In addition, both acute and chronic modula-
tions of cardiomyocyte Fpassive occur via altered titin phosphorylation. Cyclic
AMP-dependent protein kinase-A, cGMP-dependent protein kinase-G, and
extracellular signal-regulated kinase-2 phosphorylate titin at a cardiac-
specific domain, the N2Bus; this phosphorylation results in a reduction in car-
diomyocyte Fpassive in various species. PKCa phosphorylates the PEVK-
domain of titin, which increases Fpassive of normal mouse cardiomyocytes,
but does not significantly alter Fpassive of cardiomyocytes obtained from a
dog HF model. Calcium/calmodulin-dependent protein kinase-II (CaMKII)
is the first kinase found to phosphorylate both the N2Bus and the PEVK-
domain. This phosphorylation reduces cardiomyocyte Fpassive, as demonstrated
in skinned mouse cardiomyocytes incubated with recombinant CaMKIId.
Moreover, Fpassive is elevated in cardiomyocytes of CaMKIIg/d double
knockout mice and reduced in those of CaMKIId-overexpressing transgenic
mice. In both human and experimental HF, a global titin phosphorylation
deficit is observed, but site-specific titin phosphorylation can be increased
or decreased in HF, presumably depending on the activity and expression level
of the relevant kinases.
Conclusion: Titin phosphorylation may have beneficial effects in the heart
via reducing myocardial diastolic stiffness and improving ventricular
filling. Altered titin phosphorylation in HF may severely affect Fpassive and
compromise cardiac function. The degree, to which the different protein ki-
nases contribute to alterations in diastolic passive stiffness, needs to be
determined.
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Cardiac myosin binding protein C (cMyBP-C) is a sarcomeric protein involved
in the regulation of cardiac muscle contraction. Effects of cMyBP-C on
contraction are thought to be mediated in part by limiting the interactions of
actin and myosin to slow myocyte shortening velocity and power output.
Although interactions with myosin S2 on the thick filament have been proposed
as a way in which cMyBP-C could limit shortening velocity (e.g., by creating a
drag force on myosin heads), interactions of cMyBP-C with actin could also
account for slowed shortening velocity. For instance, cMyBP-C could create
a drag that opposes filament sliding by transiently linking thick and thin fila-
ments together. To explore this possibility we created transgenic mice that ex-
press a mutant cMyBP-C with a point mutation (L348P) located in a conserved
sequence within the regulatory M-domain that increases cMyBP-C binding to
actin in vitro (Bezold et al, JBC, 2013). We reasoned that if the mutation also
enhanced binding to actin in sarcomeres then shortening velocity would be
slowed in myocytes from L348P mice. Results show that transgenic mice ex-
pressing the L348P mutation are viable and that L348P cMyBP-C is expressed
in sarcomeres. Permeabilized myocytes from transgenic mice showed altered
force production including reduced maximal force and enhanced Ca2þ sensi-
tivity of tension. Shortening velocity and power output were significantly
reduced whereas passive stiffness and myocyte visco-elasticity were signifi-
cantly increased. Together these data are consistent with the idea that
cMyBP-C creates an internal load in the sarcomere by binding to actin. Thiswork supported by NIH R01 HL080367 (SPH) and an AHA graduate fellow-
ship (KLB).
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Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac
disorder. Mutations in the gene (MYBPC3) encoding cardiac myosin binding
protein C (cMyBP-C) are a frequent cause of HCM. Clinical as well as
animal-model studies have reported sex-related differences in HCM disease
onset and severity. In addition, it has been established that physiological
stimuli such as exercise may elicit a sexually dimorphic cardiac response.
However, less attention has been paid to the sex-specific differences in the
cellular pathophysiologic mechanisms underlying HCM. Therefore, we
studied functional properties of the heart and sarcomeres in male and
female sedentary and exercise (exposed to 8 weeks voluntary wheel running)
mice.
Echocardiography and isometric force measurements in mechanically isolated
left ventricular (LV) membrane-permeabilized cardiomyocytes were per-
formed in Wild-type (WT) and heterozygous (HET) knock-in mice carrying
a Mybpc3 point mutation (G>A transition) associated with HCM.
The LV mass was significantly lower in female WT and HET mice (23% in
WT and 25% in HET), compared to corresponding male mice. Isometric
force measurements revealed a significant lower maximal generated tension
(Fmax) in HET male (13.0 51.1 kN/m
2), than in females (20.0 52.2 kN/
m2). Exercise induced a higher fractional shortening in HET male mice,
which is correlated with an increased Fmax in exercised HET males. In
contrast, LV weight was significantly increased in exercised HET females
compared to sedentary females (7% in WT and 15% in HET). Ca2þ-sensi-
tivity was increased in exercised male and females WT mice. Similarly,
Ca2þ-sensitivity was enhanced in HET females, however not in exercised
HET mice.
In conclusion, exercise training improved cardiac and myofilament perfor-
mance particularly in HET male mice, indicating that physiological stimuli
may elicit a sexually dimorphic cardiac response in heterozygous Mybpc3-tar-
geted knock-in mice.
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Background
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder with a
prevalence of 1:500. In ~65% of all HCM patients the causative mutation is
identified. HCM patients that are sarcomere-mutation negative tend to have a
less severe phenotype. Mutations in the MYBPC3 and MYH7 genes encoding
cardiac myosin-binding protein C (cMyMP-C) and b-myosin heavy chain
(MyHC) represent >80% of all genotyped HCM cases. HCM is characterized
by asymmetric hypertrophy of the left ventricle and diastolic dysfunction. In
the present study we investigated if passive stiffness of the sarcomeres may un-
derlie diastolic dysfunction.
Methods
In-vitro passive tension measurements were done at sarcomere lengths of 1.8 to
2.2mm in cardiomyocytes from 10 sarcomere mutation-negative patients(SMN:
5 male, 5 female), 17 patients carrying a MYBPC3 mutation(MYBPC3: 10
male, 7 female), and 10 patients carrying a MYH7 mutation (MYH7: 5 male,
5 female). Tissue was obtained during myectomy surgery from the interventric-
ular septum. Cardiomyocytes were mechanically isolated and Triton-
permeabilized.
